关注
Eiman Aleem, Ph.D.
Eiman Aleem, Ph.D.
Professor and research group leader, London South Bank University
在 lsbu.ac.uk 的电子邮件经过验证
标题
引用次数
引用次数
年份
Cdk2 knockout mice are viable
C Berthet, E Aleem, V Coppola, L Tessarollo, P Kaldis
Current biology 13 (20), 1775-1785, 2003
8372003
Cdc2–cyclin E complexes regulate the G1/S phase transition
E Aleem, H Kiyokawa, P Kaldis
Nature cell biology 7 (8), 831-836, 2005
4902005
Targeting cell cycle regulators in hematologic malignancies
E Aleem, RJ Arceci
Frontiers in cell and developmental biology 3, 16, 2015
1562015
Cell cycle sibling rivalry: Cdc2 versus Cdk2
P Kaldis, E Aleem
Cell cycle 4 (11), 1491-1494, 2005
1262005
Dependence of cisplatin-induced cell death in vitro and in vivo on cyclin-dependent kinase 2
PM Price, F Yu, P Kaldis, E Aleem, RL Safirstein, J Megyesi
Journal of the American Society of Nephrology 17 (9), 2434-2442, 2006
1182006
IL-7 promotes T cell proliferation through destabilization of p27Kip1
WQ Li, Q Jiang, E Aleem, P Kaldis, AR Khaled, SK Durum
The Journal of experimental medicine 203 (3), 573-582, 2006
1142006
β-Glucans and their applications in cancer therapy: focus on human studies
E Aleem
Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2013
942013
Upregulation of the insulin receptor and type I insulin-like growth factor receptor are early events in hepatocarcinogenesis
E Aleem, D Nehrbass, F Klimek, D Mayer, P Bannasch
Toxicologic pathology 39 (3), 524-543, 2011
832011
Cdk2 as a master of S phase entry: fact or fake?
E Aleem, C Berthet, P Kaldis
Cell Cycle 3 (1), 34-36, 2004
642004
Schizophyllan inhibits the development of mammary and hepatic carcinomas induced by 7, 12 dimethylbenz (α) anthracene and decreases cell proliferation: comparison with tamoxifen
A Mansour, A Daba, N Baddour, M El-Saadani, E Aleem
Journal of cancer research and clinical oncology 138, 1579-1596, 2012
602012
Disulfiram overcomes bortezomib and cytarabine resistance in Down-syndrome-associated acute myeloid leukemia cells
R Bista, DW Lee, OB Pepper, DO Azorsa, RJ Arceci, E Aleem
Journal of Experimental & Clinical Cancer Research 36, 1-14, 2017
492017
Serum IGFBP‑3 is a more effective predictor than IGF‑1 and IGF-2 for the development of hepatocellular carcinoma in patients with chronic HCV infection
E Aleem, A Elshayeb, N Elhabachi, AR Mansour, A Gowily, A Hela
Oncology letters 3 (3), 704-712, 2012
482012
PRKAR1A inactivation leads to increased proliferation and decreased apoptosis in human B lymphocytes
AJ Robinson-White, WW Leitner, E Aleem, P Kaldis, I Bossis, CA Stratakis
Cancer research 66 (21), 10603-10612, 2006
462006
Cdk2 and Cdk4 activities are dispensable for tumorigenesis caused by the loss of p53
VC Padmakumar, E Aleem, C Berthet, MB Hilton, P Kaldis
Molecular and cellular biology 29 (10), 2582-2593, 2009
432009
Nuclear insulin-like growth factor 1 receptor phosphorylates proliferating cell nuclear antigen and rescues stalled replication forks after DNA damage
A Waraky, Y Lin, D Warsito, F Haglund, E Aleem, O Larsson
Journal of Biological Chemistry 292 (44), 18227-18239, 2017
382017
Nanoparticle-mediated cancer cell therapy: Basic science to clinical applications
J Verma, C Warsame, RK Seenivasagam, NK Katiyar, E Aleem, S Goel
Cancer and Metastasis Reviews 42 (3), 601-627, 2023
342023
Picropodophyllin causes mitotic arrest and catastrophe by depolymerizing microtubules via insulin-like growth factor-1 receptor-independent mechanism
A Waraky, K Akopyan, V Parrow, T Strömberg, M Axelson, L Abrahmsén, ...
Oncotarget 5 (18), 8379, 2014
292014
CDK2 is required by MYC to induce apoptosis
D Deb-Basu, E Aleem, P Kaldis, DW Felsher
Cell Cycle 5 (12), 1342-1347, 2006
262006
Mouse models of cell cycle regulators: new paradigms
E Aleem, P Kaldis
Cell Cycle Regulation, 271-328, 2006
252006
Induction of leukaemia in chloramphenicol-treated toads.
AEA el-Mofty MM, Abdelmeguid NE, Sadek IA, Essawy AE
East Mediterr Health J. 6 (5-6), 1026-34., 2000
25*2000
系统目前无法执行此操作,请稍后再试。
文章 1–20